Gastrointestinal Cancer News

Alcohol consumption appeared linked to more than 740,000 new cancer diagnoses in 2020, equivalent to 4% of cases worldwide.

Short-term radiotherapy combined with chemotherapy may be a suitable alternative to long-term radiotherapy for patients with advanced rectal cancer, according to data from a multicenter, randomized, phase 3 trial presented at ASCO21.

When combined with trastuzumab and chemotherapy, pembrolizumab significantly increased overall response rate in patients with HER2 positive metastatic gastric or gastroesophageal junction cancer, according to data from a phase 3, randomized study of 1L pembrolizumab compared with chemotherapy.

Maintenance therapy with 5-fluoruracil/leucovorin plus panitumumab better maintained wildtype metastatic colorectal cancer than 5-fluoruracil/leucovorin alone, according to data from a study presented at ASCO21.

Experts continued to see a decrease in overall cancer mortality among men and women of all races and ethnicities in the United States toward the end of the last decade, according to the Annual Report to the Nation on the Status of Cancer.

Transarterial radioembolization was a well-tolerated first-line treatment among patients with hepatocellular carcinoma, according to research presented at the International Liver Congress.

Glucose variability was an independent predictor of hepatocellular carcinoma, according to research presented at The International Liver Congress.

Patients with cancer have elevated risk for atrial fibrillation development, although the degree varies by cancer type, researchers reported in JACC: CardioOncology.

Researchers validated a liver cancer risk test algorithm for identifying patients with chronic hepatitis C at low risk for hepatocellular carcinoma, according to a study presented at The Digital International Liver Congress.

Researchers have identified a possible molecular link between high consumption of both processed and unprocessed red meat and increased colorectal cancer risk and mortality.